Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology. It develops portfolio of innate immune system programs, designed to functionally repair genetic mutations and enable the rejuvenated immune cells to counteract emerging brain pathologies. Its treatment targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in May 2013 and is headquartered in South San Francisco, CA.
Subscribe to see Alector, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Alector, Inc. is a biotech company headquartered in South San Francisco, United States. It is publicly listed (ALEC) with a market capitalisation of $221.2M. Xcout tracks 20 named people at Alector, Inc., including Neil Berkley (CFO & Chief Business Officer). Xcout recorded 11 job postings from Alector, Inc. in the last 90 days.
14 more named people on record for Alector, Inc., with roles, board committees and tenure — see the full roster →
Xcout recorded 11 job postings from Alector, Inc. in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see Alector, Inc.'s hiring signals →
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.